Why a polynucleotide skin cream repairs tissue differently from a conventional moisturiser — and why the distinction is clinically meaningful

What polynucleotides are and why they were originally developed for wound healing

Polynucleotides — specifically PDRN (polydeoxyribonucleotide) and PN (polynucleotide) — are DNA-derived fragments originally developed and clinically validated in wound healing and tissue repair medicine. They work through purinergic receptor activation, stimulating fibroblast activity and promoting the synthesis of collagen, elastin and hyaluronic acid by the skin's own cells rather than delivering these molecules from the outside. This biological activity pathway — stimulating the skin to produce its own structural proteins rather than supplementing them topically — is mechanistically distinct from how conventional moisturisers or even peptide creams work.

The visible difference between hydration support and tissue-level repair over time

A conventional moisturiser delivers immediate hydration and barrier support that produces a visible improvement in skin appearance within hours of application. The effect is real and valuable — sustained use maintains barrier integrity, reduces water loss, and keeps the skin surface in better condition. Polynucleotide creams also provide this surface-level benefit, but their additional mechanism — fibroblast stimulation and extracellular matrix support — produces a structural improvement that develops more slowly and persists differently. Tissue-level changes in collagen density and skin firmness take weeks to months to become visible, but they represent a different category of improvement than hydration alone.

PDRN cream versus PDRN injectable — understanding the topical adaptation of a clinical ingredient

PDRN injections have a well-established clinical evidence base for tissue repair, particularly in post-procedure recovery and scar remodelling. Topical PDRN cream is an adaptation that delivers the same molecule through the skin barrier rather than beneath it. Penetration depth is necessarily shallower than injection, which means the dermal fibroblast stimulation effect is less direct — but it is measurably present in repeated-use trials, and the topical format is accessible for daily use rather than requiring clinical procedures. The topical version is best understood as a maintenance and support tool, not a replacement for clinical treatment.

Choosing between polynucleotide formulations for home repair support

Both PDRN and PN formulations occupy the same functional category — stimulating skin's own repair mechanisms for structural improvement over time. A polynucleotide cream used after active skin treatments (professional peels, laser, microneedling) accelerates the recovery phase and amplifies the treatment outcome. Used as part of a daily preventive routine, it provides ongoing fibroblast support that helps the skin maintain structural integrity as it ages. The combination of two PDRN-category products at different concentrations or vehicle types covers both the intensive recovery and the sustained daily maintenance scenarios.

REJURAN Turnover Active Cream 50ml — available on BuyBeautyKorea →

VT PDRN Glow Cream 50mL — available on BuyBeautyKorea →